Latest AI and machine learning research in chemotherapy for healthcare professionals.
Chemotherapy resistance remains a primary cause of treatment failure in breast cancer, yet the global proteomic landscape driving this phenotype has not been completely understood. In this study, we employed a systematic multiomics approach, integrating quantitative proteomics of doxorubicin-resistant cells with transcriptomic and proteomic data from large-scale clinical cohorts (TCGA and FUSCC). ...
PURPOSE: PPOI is one of the common complications of intraperitoneal hyperthermic chemotherapy during laparoscopic radical resection of rectal cancer, which seriously affects the prognosis of patients. The purpose of this study is to establish a prediction system for PPOI secondary to laparoscopic radical resection of rectal cancer combined with intraperitoneal hyperthermic chemotherapy with lobapl...
Dual-mode sensors with ultrahigh sensitivity, wide detection range, linearity, and stable temperature response are highly desirable for monitoring in ...
Accurate prediction of disease-free survival (DFS) is essential for tailoring adjuvant regimens and improving clinical outcomes in early-stage breast ...
OBJECTIVES: To develop a nomogram model for individualized prediction of neoadjuvant chemotherapy (NAC) response in locally advanced laryngeal cancer ...
BACKGROUND: Due to immunosuppression, mucosal barrier injury, and prolonged neutropenia resulting from both the disease and chemotherapy, along with t...
Nanobots are small nanoscale devices designed to perform highly specific tasks in precisely targeted areas, representing a promising approach in the d...
Early assessment of treatment response is essential for optimizing cancer management, as it allows timely interventions during the course of therapy, ...
The Oncotype DX assay has revolutionized the management of early-stage, hormone receptor-positive, HER2-negative breast cancer. Developed in 2004, it ...
Colorectal cancer(CRC) recurrence remains a challenge despite curative surgery and adjuvant therapy. Integrating clinicopathological and liquid biopsy...
BACKGROUND: High-grade serous ovarian cancer (HGSOC) is the most lethal ovarian cancer subtype, responsible for ~ 70% of ovarian cancer-related deaths...
Deep learning has rapidly emerged as a transformative technology in oncology, offering new capabilities in treatment response prediction and personali...
INTRODUCTION: Adenoid cystic carcinoma (ACC) of the head and neck is a rare malignancy characterized by perineural invasion, local recurrence, and dis...
PURPOSE: To synthesize and critically appraise evidence from systematic reviews and meta-analyses on pterygium, identifying domains with robust suppor...
BACKGROUND: Periodontitis is a chronic inflammatory disease driven by host immune dysregulation. However, the specific genetic regulatory mechanisms u...
PURPOSE: Atypical teratoid/rhabdoid tumor (AT/RT) is a rare and highly malignant pediatric brain tumor with dismal prognosis. We aimed to characterize...
BACKGROUND: Oxaliplatin (OXA) is widely used in the treatment of gastrointestinal malignancies such as colorectal cancer. However, oxaliplatin-induced...
Gastrointestinal stromal tumor (GIST) is the most common gastrointestinal mesenchymal tumor, driven by tyrosine-protein kinase (KIT) and platelet-deri...